Pharmaceuticals, Biotechnology and Life Sciences
PHOENIX–(BUSINESS WIRE)–Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in combating Type…
CHS Becomes First Health System to Purchase Drugs Manufactured by Cost Plus Drugs FRANKLIN, Tenn.–(BUSINESS WIRE)–Community Health Systems, Inc. (NYSE:…
Study underscores the value of a multi-omic approach to examine cell-intrinsic and -extrinsic factors governing progression and therapeutic outcomes in…
CHARLOTTE, N.C.–(BUSINESS WIRE)–Catawba Research, a prominent global clinical research organization (CRO), today introduced Julie Arnold as its vice president of…
BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced…
Company will also present new preclinical data for its orthoIL-2 technology for cytokine-inducible cell therapies MENLO PARK, Calif.–(BUSINESS WIRE)–Synthekine Inc.,…
Debiopharm aims to further characterize the safety, tolerability, and preliminary anti-tumor activity of its potent WEE1 inhibitor Debio 0123 as…
Womed Leaf® reduces severe and moderate intrauterine adhesions, the primary mechanical cause for female infertility MONTPELLIER, France–(BUSINESS WIRE)–#femtech–Womed, the women’s…
NEW YORK–(BUSINESS WIRE)–$MNMD—Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company…
Dirk Van Hyfte MD, PhD, Co-Founder and Head of Innovation of BioStrand, to present findings live next week at the…